{
    "doi": "https://doi.org/10.1182/blood.V128.22.3007.3007",
    "article_title": "Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Anaplastic Large Cell Lymphoma ",
    "article_date": "December 2, 2016",
    "session_type": "624. Hodgkin Lymphoma and T/NK Cell Lymphoma-Clinical Studies: Poster II",
    "abstract_text": "From November 2012 to July 2014, brentuximab vedotin (BV) was available in Italy for patients with relapsed systemic anaplastic large cell lymphoma (ALCL) outside a clinical trial context based on a local disposition of the Italian Drug Agency (AIFA) issued according to a national law (Law 648/96: \"medicinal products that are provided free of charge on the national health service\"). A large Italian observational retrospective study was conducted on the use of BV in the everyday clinical practice to check if clinical trial results are confirmed even in a real life context. Primary endpoint was the best response; secondary endpoints were the overall response rate at the end of the treatment, duration of response, survival and the safety profile. BV was infused intravenously at the dose of 1.8 mg/kg every 3 weeks for a maximum of 16 cycles. A total of 40 ALCL (18 anaplastic lymphoma kinase [ALK] negative and 22 ALK-positive status) patients were treated with BV in 40 Hematology Centers. All patients had histologically documented CD30+ ALCL; 16 (40%) had relapsed and 24 (60%) had refractory disease. Patients were heavily pretreated with a median of 2 previous therapies (including autologous transplant in the 32.5% of cases). Best response was observed after a median of 4 cycles in 31 patients (77.5%): 19 (47.5%) patients obtained a complete response (CR) and 12 (30%) achieved a partial response (PR); overall response rate at the end of the treatment was 62.5% (18 CR and 7 PR). The best response rate was higher in the elderly subset (>60 years): 9 (64.2%) CR and 3 (21.4%) PR, achieving a total of 85.6%. At the latest follow up 15/18 patients are still in CR (3 with consolidative procedure). Global progression free survival was 39.1% at 29 months and disease free survival 54% at 23.9 months (median not reached). Median duration of response was 12 months (range 9-24 months). We identified 5 long term responders (patients with a response \u2265 12 months), all were still in CR at the latest follow up (1 underwent allogeneic transplant). Particularly, all the long term responders were aged <30 years at first BV infusion. All patients were included in the safety profile for the analysis; in general, the treatment was well tolerated even in this real life context and the toxicity profile was closely similar to the previously published data; no death has been linked to BV toxicity. Toxicity was primarily neurological and rarely so serious as to require treatment reduction or interruption; furthermore, neurological toxicity always reversed completely after end of treatment. No long-term toxicity was assessed during the follow-up period, even in patients later subjected to transplant consolidation. BV induces clinical responses quite rapidly, i.e. within the first 4 cycles in most responders, thus permitting the timely application of the transplantation phase. Furthermore, BV displays a favorable toxicity profile, without overlapping toxicities with most of the agents employed in high-dose conditioning regimens. For patients ineligible for transplant or for who transplant failed, BV may represent a feasible effective therapeutic option in everyday clinical practice. Disclosures Rusconi: Takeda: Consultancy; Teva: Consultancy, Other: Congress attendance; Janssen: Consultancy, Other: Congress attendance. Spina: Mundipharma: Membership on an entity's Board of Directors or advisory committees, Other: Speaker Fee; Teva Pharmaceuticals Industries: Membership on an entity's Board of Directors or advisory committees, Other: Speaker Fee. Zinzani: Abbvie: Membership on an entity's Board of Directors or advisory committees; Janssen: Membership on an entity's Board of Directors or advisory committees; MorphoSys: Membership on an entity's Board of Directors or advisory committees; Takeda: Membership on an entity's Board of Directors or advisory committees; Celegene: Membership on an entity's Board of Directors or advisory committees; Roche: Membership on an entity's Board of Directors or advisory committees.",
    "topics": [
        "brentuximab vedotin",
        "ki-1+ anaplastic large cell lymphoma",
        "observational studies",
        "toxic effect",
        "transplantation",
        "follow-up",
        "anaplastic lymphoma kinase",
        "complete remission",
        "duration of treatment",
        "infusion procedures"
    ],
    "author_names": [
        "Cinzia Pellegrini",
        "Luigi Rigacci",
        "Caterina Patti, MD",
        "Guido Gini, MD",
        "Donato Mannina, MD",
        "Monica Tani",
        "Chiara Rusconi, MD",
        "Alessandra Romano, MD PhD",
        "Anna Vanazzi, MD",
        "Barbara Botto",
        "Carmelo Carlo-Stella, MD",
        "Stefan Hohaus",
        "Gian Matteo Rigolin",
        "Pellegrino Musto, MD",
        "Patrizio Mazza, MD",
        "Stefano Molica, MD",
        "Paolo Corradini",
        "Angelo Fama, MD",
        "Francesco Gaudio",
        "Michele Merli",
        "Angela Gravetti",
        "Giuseppe Gritti, MD",
        "Annalisa Arcari",
        "Patrizia Tosi",
        "Anna Marina Liberati, MD",
        "Antonello Pinto",
        "Vincenzo Pavone, MD",
        "Filippo Gherlinzoni, MD",
        "Virginia Naso",
        "Stefano Volpetti",
        "Andrea Visentin, MD",
        "Maria Cecilia Goldaniga, MD",
        "Maurizio Bonfichi, MD",
        "Amalia De Renzo",
        "Corrado Schiavotto",
        "Michele Spina",
        "Sergio Storti, MD",
        "Angelo Michele Carella",
        "Lisa Argnani",
        "Pier Luigi Zinzani, MD PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Cinzia Pellegrini",
            "author_affiliations": [
                "Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Luigi Rigacci",
            "author_affiliations": [
                "Hematology Department, University and Hospital Careggi, Firenze, Italy "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caterina Patti, MD",
            "author_affiliations": [
                "Dept. of Hematology, Azienda Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guido Gini, MD",
            "author_affiliations": [
                "Department of Hematology, Ospedali Riuniti di Ancona, Ancona, Italy "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Donato Mannina, MD",
            "author_affiliations": [
                "Hematology Unit, Ospedale Papardo, Messina, Italy "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Tani",
            "author_affiliations": [
                "Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Chiara Rusconi, MD",
            "author_affiliations": [
                "Division of Hematology, Niguarda Hospital, Milan, Italy "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandra Romano, MD PhD",
            "author_affiliations": [
                "Division of Haematology, AOU, Catania, Italy "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Vanazzi, MD",
            "author_affiliations": [
                "European Institute of Oncology, Milano, Italy "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Barbara Botto",
            "author_affiliations": [
                "SC Ematologia, Azienda Ospedaliera Universitaria Citt\u00e0 della Salute e della Scienza, Torino, Italy "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carmelo Carlo-Stella, MD",
            "author_affiliations": [
                "Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefan Hohaus",
            "author_affiliations": [
                "Institute of Hematology, Catholic University, Rome, Italy "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gian Matteo Rigolin",
            "author_affiliations": [
                "Hematology Section, Azienda Ospedaliero-Universitaria S. Anna, University of Ferrara, Ferrara, Italy "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pellegrino Musto, MD",
            "author_affiliations": [
                "CROB Rionero in Vulture, Roma, Italy "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Patrizio Mazza, MD",
            "author_affiliations": [
                "C/O Ospedale Moscati Dept. of Hematology-Oncology, Taranto, Italy "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefano Molica, MD",
            "author_affiliations": [
                "Department of Hematology, Ciaccio-Pugliese Hospital, Catanzaro, Italy "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paolo Corradini",
            "author_affiliations": [
                "Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angelo Fama, MD",
            "author_affiliations": [
                "Hematology Unit, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesco Gaudio",
            "author_affiliations": [
                "Hematology Unit, Policlinico di Bari, Bari, Italy "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Merli",
            "author_affiliations": [
                "Hematology, Ospedale di Circolo, Fondazione Macchi, Varese, Italy "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angela Gravetti",
            "author_affiliations": [
                "Division of Hematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Napoli, Italy "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Gritti, MD",
            "author_affiliations": [
                "Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Annalisa Arcari",
            "author_affiliations": [
                "Division of Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Patrizia Tosi",
            "author_affiliations": [
                "Hematology Unit, Infermi Hospital Rimini, Rimini, Italy "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Marina Liberati, MD",
            "author_affiliations": [
                "Hematology, Ospedale Perugia, Perugia, Italy "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonello Pinto",
            "author_affiliations": [
                "Hematology-Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Fondazione Pascale, IRCCS, Napoli, Italy "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vincenzo Pavone, MD",
            "author_affiliations": [
                "Division of Hematology, Ospedale G. Panico, Tricase, Lecce, Italy "
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Filippo Gherlinzoni, MD",
            "author_affiliations": [
                "Hematology Unit, Ca' Foncello Hospital, Treviso, Italy "
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Virginia Naso",
            "author_affiliations": [
                "Sant'Andrea Hospital - Sapienza, Roma, Italy "
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefano Volpetti",
            "author_affiliations": [
                "Department of Hematology, DISM, Azienda Sanitaria Universitaria Integrata, Udine, Italy "
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andrea Visentin, MD",
            "author_affiliations": [
                "Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy "
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Cecilia Goldaniga, MD",
            "author_affiliations": [
                "OncoHematology Unit, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico, Milan, Italy "
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maurizio Bonfichi, MD",
            "author_affiliations": [
                "Hematology, IRCCS Policlinico San Matteo, Pavia, Italy "
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Amalia De Renzo",
            "author_affiliations": [
                "Hematology, AOU Federico II Napoli, Napoli, Italy "
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Corrado Schiavotto",
            "author_affiliations": [
                "Hematology, San Bortolo Hospital, Vicenza, Italy "
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Spina",
            "author_affiliations": [
                "Division of Medical Oncology A, National Cancer Institute, Aviano, Italy "
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sergio Storti, MD",
            "author_affiliations": [
                "Hematology, Universit\u00e0 Cattolica Sacro Cuore Campobasso, Campobasso, Italy "
            ],
            "author_rank": 37,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angelo Michele Carella",
            "author_affiliations": [
                "Division of Hematology 1, IRCCS A.O.U. San Martino IST, Genova, Italy"
            ],
            "author_rank": 38,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lisa Argnani",
            "author_affiliations": [
                "Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 39,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pier Luigi Zinzani, MD PhD",
            "author_affiliations": [
                "Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 40,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-08T18:34:58",
    "is_scraped": "1"
}